Back to Agendas
Welcome to Day 3 and Track Report Outs
Session Chair(s)
Jim Zisek
Director, Global CMC Regulatory Affairs
GlaxoSmithKline, United States
Welcome to Day 3 and Track Report Outs
Speaker(s)
Welcome Remarks
Jim Zisek
GlaxoSmithKline, United States
Director, Global CMC Regulatory Affairs
CMC Track Report Out
Daniel Capaldi, PhD
Ionis Pharmaceuticals, Inc, United States
Vice President, Analytical and Process Development
Non Clinical Track Report Out
Ronald Wange, PhD
FDA, United States
Associate Director for Pharm/Tox, OND, CDER
Clinical Track Report Out
Arthur M. Krieg, MD
Checkmate Pharmaceuticals, United States
CEO and CSO
Have an account?